Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis

Etiology, Management, and Outcome of the Budd-Chiari Syndrome

(2013) Sarwa Darwish Murad   ANNALS OF INTERNAL MEDICINE

Budd-Chiari Syndrome: Long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt

(2012) Alexandra Zahn et al.   BMC GASTROENTEROLOGY

Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis

(2011) X. Qi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis

(2011) Jasper H. Smalberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms

(2011) J. HOEKSTRA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis

(2010) Niamh McCarthy et al.   ACTA HAEMATOLOGICA

The epidemiology and clinical features of portal vein thrombosis: a multicentre study

(2010) R. Rajani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis

(2010) D. W. ORR et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

JAK2Mutations Across a Spectrum of Venous Thrombosis Cases: Table 1

(2010) Shrimati Shetty et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience

(2010) Rupesh Rajani et al.   LIVER INTERNATIONAL

JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

(2009) F. Dentali et al.   BLOOD

The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome

(2009) S. Sozer et al.   BLOOD

Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome

(2009) Donatella Colaizzo et al.   BLOOD COAGULATION & FIBRINOLYSIS

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

(2009) Sandra Guerra Xavier et al.   DIGESTIVE DISEASES AND SCIENCES

Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study

(2009) Aurelie Plessier et al.   HEPATOLOGY

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

(2009) Ayalew Tefferi et al.   Nature Reviews Clinical Oncology

Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms

(2008) Alessia Fiorini et al.   AMERICAN JOURNAL OF HEMATOLOGY

MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction

(2008) G. M. Bergamaschi et al.   BLOOD

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD

Undiagnosed Myeloproliferative Disease in Cases of Intra-Abdominal Thrombosis: The Utility of the JAK2 617F Mutation

(2008) Stephanie P’ng et al.   Clinical Gastroenterology and Hepatology

JAK2V617F Mutation in Patients with Portal Vein Thrombosis

(2008) Yusuf Bayraktar et al.   DIGESTIVE DISEASES AND SCIENCES

Vascular disorders of the liver

(2008) Laurie D. DeLeve et al.   HEPATOLOGY

Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation

(2008) R Landolfi et al.   LEUKEMIA

Etiology and portal vein thrombosis in Budd-Chiari syndrome

(2008) Oguz Uskudar et al.   WORLD JOURNAL OF GASTROENTEROLOGY

TheJAK2V617Ftyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis

(2007) C. GOULDING et al.   International Journal of Laboratory Hematology